(Q73795156)
Statements
The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia (English)
S B Marley
M W Deininger
R J Davidson
J M Goldman